Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2011 (Vol. 31, No. 18)

Health Landscape

URL:www.healthlandscape.org
  • Opportunities to upload and share data; interactive maps
  • Not entirely supported by all browsers

During the past few years the topic of healthcare reform has scarcely left the headlines. You have probably heard about the problems facing primary care physicians and the benefits of extending health insurance to populations who previously went without, but you may have been left wondering about some other aspects of healthcare in this country. For instance, where exactly are the regions facing a shortage of primary care physicans? And what are the healthcare demographics of different communities? If you’re looking to find such descriptions of the health landscape in the U.S., then look no further than…well, HealthLandscape. This online, interactive atlas provides four interfaces to promote the sharing and analysis of healthcare data by researchers, policy makers, and health professionals. For example, custom maps and tables can be made with the Community HealthView feature, while the Primary Care Atlas provides information about physician shortages.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »